Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$532,678
+$22,496 QoQ
Shares Held
1,471
+1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,139
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dana Investment Advisors, Inc. holds $103,613,510 across 8 Drug Manufacturers - General names. AMGN ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,592 | $42,690,116 | |
| 2 | ABBV |
AbbVie Inc.
|
157,662 | $39,674,065 | |
| 3 | JNJ |
Johnson & Johnson
|
34,927 | $8,870,410 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,543 | $6,237,775 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
44,825 | $2,582,816 | |
| 6 | PFE |
Pfizer Inc
|
75,072 | $1,807,733 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,640 | $1,217,917 | |
| 8 | AMGN |
Amgen Inc
This page
|
1,471 | $532,678 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $532,678 | 1,471 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $510,182 | 1,450 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $461,507 | 1,410 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $397,902 | 1,410 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $399,270 | 1,430 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $455,486 | 1,462 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $378,970 | 1,454 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $465,915 | 1,446 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $454,302 | 1,454 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $424,774 | 1,494 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $366,937 | 1,274 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $453,398 | 1,687 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $384,538 | 1,732 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $418,711 | 1,732 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $502,955 | 1,915 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $265,070 | 1,176 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $416,043 | 1,710 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $303,967 | 1,257 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $282,787 | 1,257 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $265,174 | 1,247 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $281,287 | 1,154 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $375,205 | 1,508 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $16,788,758 | 73,020 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $22,020,168 | 86,639 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $22,020,833 | 93,364 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $21,817,397 | 107,618 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||